Jane C Figueiredo
Overview
Explore the profile of Jane C Figueiredo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
230
Citations
5357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Viskochil R, Lin T, Gigic B, Himbert C, Bandera V, Skender S, et al.
J Cancer Surviv
. 2025 Feb;
PMID: 39985691
Purpose: Physical activity plays key roles in colorectal cancer survivorship; however, the impact of different clinicodemographic outcomes on cross-sectional and longitudinal objectively measured physical activity 12 and 24 months post-diagnosis...
2.
Alduhayh S, Laskar R, Jiang X, Zhu Z, Vincent E, Constantinescu A, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Feb;
PMID: 39982694
Background: Tumor immunosurveillance theory supports that allergic conditions could decrease cancer risk. However, observational evidence yielded inconsistent results for the association between allergic diseases and colorectal cancer risk. We used...
3.
Sankar K, Mercer J, Jaeger E, Godden J, Williams E, Thompson M, et al.
Lung Cancer
. 2025 Feb;
201:108444.
PMID: 39961190
Purpose: DNA damage response and repair (DDR) gene alterations contribute to genomic instability and increased tumor immunogenicity, yet their clinical significance in non-small cell lung cancer (NSCLC) remains unclear. Using...
4.
Smith K, Gudenkauf L, Hoogland A, Li X, Hoobler R, Playdon M, et al.
Nutrients
. 2024 Nov;
16(22).
PMID: 39599646
Purpose: To characterize dietary patterns and examine associations with cross-sectional and longitudinal changes in quality of life (QOL) over approximately one year after colorectal cancer (CRC) diagnosis. Methods: The ColoCare...
5.
Ilozumba M, Lin T, Hardikar S, Byrd D, Round J, Stephens W, et al.
Cancer Med
. 2024 Nov;
13(22):e70431.
PMID: 39587707
Background: Cachexia accounts for about 20% of all cancer-related deaths and indicates poor prognosis. The impact of Fusobacterium nucleatum (Fn), a microbial risk factor for colorectal cancer (CRC), on the...
6.
McGee H, Bonner J, Egelston C, Fu Y, Flores O, Lindsey S, et al.
medRxiv
. 2024 Oct;
PMID: 39464256
The incidence of colorectal cancer (CRC) among individuals under age 50, or early-onset CRC (EOCRC), has been rising over the past few decades for unclear reasons, and the etiology of...
7.
Lorona N, Himbert C, Ose J, Cohen S, Strehli I, Ulrich C, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Oct;
34(1):59-66.
PMID: 39373623
Background: Findings from studies investigating the impacts of alcohol use and smoking on colorectal cancer outcomes are inconclusive. This study aimed to investigate associations between alcohol use and smoking status...
8.
Thomas C, Lin Y, Kim M, Kawaguchi E, Qu C, Um C, et al.
Epidemiology
. 2024 Sep;
36(1):126-138.
PMID: 39316822
Background: Colorectal cancer (CRC) is a common, fatal cancer. Identifying subgroups who may benefit more from intervention is of critical public health importance. Previous studies have assessed multiplicative interaction between...
9.
Damerell V, Klaassen-Dekker N, Brezina S, Ose J, Ulvik A, van Roekel E, et al.
Int J Cancer
. 2024 Sep;
156(3):552-565.
PMID: 39308420
Alterations within the tryptophan-kynurenine metabolic pathway have been linked to the etiology of colorectal cancer (CRC), but the relevance of this pathway for prognostic outcomes in CRC patients needs further...
10.
Figueiredo J, Levy J, Choi S, Xu A, Merin N, Hamid O, et al.
iScience
. 2024 Sep;
27(9):110596.
PMID: 39286512
Patients with cancer are at increased risk of death from COVID-19 and have reduced immune responses to SARS-CoV2 vaccines, necessitating regular boosters. We performed comprehensive chart reviews, surveys of patients...